Leucine repeats and an adjacent DNA binding domain mediate the formation of functional cFos-cJun heterodimers - PubMed (original) (raw)
. 1989 Mar 31;243(4899):1689-94.
doi: 10.1126/science.2494701.
Affiliations
- PMID: 2494701
- DOI: 10.1126/science.2494701
Leucine repeats and an adjacent DNA binding domain mediate the formation of functional cFos-cJun heterodimers
R Turner et al. Science. 1989.
Abstract
The discovery that the AP-1 family of enhancer binding factors includes a complex of the cellular Fos (cFos) and cellular Jun (cJun) proteins established a direct and important link between oncogenesis and transcriptional regulation. Homodimeric cJun protein synthesized in vitro is capable of binding selectively to AP-1 recognition sites, whereas the cFos polypeptide is not. When cotranslated, the cFos and cJun proteins can form a stable, heterodimeric complex with the DNA binding properties of AP-1/cJun. The related proteins Jun B and vJun are also able to form DNA binding complexes with cFos. Directed mutagenesis of the cFos protein reveals that a leucine repeat structure is required for binding to cJun, in a manner consistent with the proposed function of the "leucine zipper." A novel domain adjacent to, but distinct from, the leucine repeat of cFos is required for DNA binding by cFos-cJun heterodimers. Thus experimental evidence is presented that leucine repeats can mediate complex formation between heterologous proteins and that promotes further understanding of the molecular mechanisms underlying the function of two proto-oncogene products.
Similar articles
- Parallel association of Fos and Jun leucine zippers juxtaposes DNA binding domains.
Gentz R, Rauscher FJ 3rd, Abate C, Curran T. Gentz R, et al. Science. 1989 Mar 31;243(4899):1695-9. doi: 10.1126/science.2494702. Science. 1989. PMID: 2494702 - Different requirements for formation of Jun: Jun and Jun: Fos complexes.
Smeal T, Angel P, Meek J, Karin M. Smeal T, et al. Genes Dev. 1989 Dec;3(12B):2091-100. doi: 10.1101/gad.3.12b.2091. Genes Dev. 1989. PMID: 2516828 - fos-jun conspiracy: implications for the cell.
Verma IM, Ransone LJ, Visvader J, Sassone-Corsi P, Lamph WW. Verma IM, et al. Ciba Found Symp. 1990;150:128-37; discussion 137-46. doi: 10.1002/9780470513927.ch9. Ciba Found Symp. 1990. PMID: 2115424 Review. - fos-jun Conspiracy: implications for the cell.
Verma IM, Ransone LJ, Visvader J, Sassone-Corsi P, Lamph WW. Verma IM, et al. Princess Takamatsu Symp. 1989;20:119-26. Princess Takamatsu Symp. 1989. PMID: 2518685 Review.
Cited by
- Transcription factor BACH1 in cancer: roles, mechanisms, and prospects for targeted therapy.
Hu D, Zhang Z, Luo X, Li S, Jiang J, Zhang J, Wu Z, Wang Y, Sun M, Chen X, Zhang B, Xu X, Wang S, Xu S, Wang Y, Huang W, Xia L. Hu D, et al. Biomark Res. 2024 Feb 7;12(1):21. doi: 10.1186/s40364-024-00570-4. Biomark Res. 2024. PMID: 38321558 Free PMC article. Review. - A Quantitative Systems Approach to Define Novel Effects of Tumour p53 Mutations on Binding Oncoprotein MDM2.
Fuentes M, Srivastava S, Gronenborn AM, LaBaer J. Fuentes M, et al. Int J Mol Sci. 2021 Dec 21;23(1):53. doi: 10.3390/ijms23010053. Int J Mol Sci. 2021. PMID: 35008477 Free PMC article. - From Proteomic Mapping to Invasion-Metastasis-Cascade Systemic Biomarkering and Targeted Drugging of Mutant BRAF-Dependent Human Cutaneous Melanomagenesis.
Giannopoulou AF, Velentzas AD, Anagnostopoulos AK, Agalou A, Papandreou NC, Katarachia SA, Koumoundourou DG, Konstantakou EG, Pantazopoulou VI, Delis A, Michailidi MT, Valakos D, Chatzopoulos D, Syntichaki P, Iconomidou VA, Tsitsilonis OE, Papassideri IS, Voutsinas GE, Hatzopoulos P, Thanos D, Beis D, Anastasiadou E, Tsangaris GT, Stravopodis DJ. Giannopoulou AF, et al. Cancers (Basel). 2021 Apr 22;13(9):2024. doi: 10.3390/cancers13092024. Cancers (Basel). 2021. PMID: 33922182 Free PMC article. - A cell-based bioluminescence assay reveals dose-dependent and contextual repression of AP-1-driven gene expression by BACH2.
Vardaka P, Lozano T, Bot C, Ellery J, Whiteside SK, Imianowski CJ, Farrow S, Walker S, Okkenhaug H, Yang J, Okkenhaug K, Kuo P, Roychoudhuri R. Vardaka P, et al. Sci Rep. 2020 Nov 3;10(1):18902. doi: 10.1038/s41598-020-75732-z. Sci Rep. 2020. PMID: 33144667 Free PMC article. - BACH2 drives quiescence and maintenance of resting Treg cells to promote homeostasis and cancer immunosuppression.
Grant FM, Yang J, Nasrallah R, Clarke J, Sadiyah F, Whiteside SK, Imianowski CJ, Kuo P, Vardaka P, Todorov T, Zandhuis N, Patrascan I, Tough DF, Kometani K, Eil R, Kurosaki T, Okkenhaug K, Roychoudhuri R. Grant FM, et al. J Exp Med. 2020 Sep 7;217(9):e20190711. doi: 10.1084/jem.20190711. J Exp Med. 2020. PMID: 32515782 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous